Eric Bjerkholt, M.B.A.
Board Member
Metagenomi Therapeutics, Inc. (MGX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Bjerkholt, M.B.A.
Eric Bjerkholt, M.B.A. is recorded as Board Member at Metagenomi Therapeutics, Inc. (MGX). Metagenomi Therapeutics, Inc. reported in an 8-K filed June 10, 2026 that Eric Bjerkholt, M.B.A. was appointed Class II Director, effective June 9, 2026.
“Juergen Eckhardt, M.D., M.B.A. and Eric Bjerkholt, M.B.A. were elected as Class II Directors to serve until the Company's 2029 annual meeting of stockholders, and until their respective successor shall have been duly elected and qualified, or until their earlier death, resignation or removal, based on the following votes:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Metagenomi Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jian Irish CEO, COO, Board Member
- Pamela Wapnick CFO
- Matthew L. Wein General Counsel
- Eric Bjerkholt Board Member
- Juergen Eckhardt Board Member
- Juergen Eckhardt, M.D., M.B.A. Board Member
- Laurence Reid Board Member
- Willard H. Dere Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.